{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:08:26Z","timestamp":1784286506431,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 MD012565"],"award-info":[{"award-number":["R01 MD012565"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA256977"],"award-info":[{"award-number":["R01 CA256977"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.surg.2025.109396","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:51:14Z","timestamp":1746499874000},"page":"109396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-6500","authenticated-orcid":false,"given":"Woo Jin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommy","family":"Ivanics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Claasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian T.J.","family":"Magyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parissa","family":"Tabrizian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grainne M.","family":"O'Kane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Reig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Ferrer F\u00e0brega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Holgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neehar D.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjana","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Hunold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arndt","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhukar S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit G.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Tadros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2025.109396_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2025.109396_bib2","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1245\/s10434-019-07911-w","article-title":"The achievement of a sustained virological response either before or after hepatectomy improves the prognosis of patients with primary hepatitis C virus-related hepatocellular carcinoma","volume":"26","author":"Okamura","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surg.2025.109396_bib3","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2019.07.040","article-title":"Direct-acting antiviral therapy for hepatitis C virus infection is associated with increased survival in patients with a history of hepatocellular carcinoma","volume":"157","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2025.109396_bib4","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.23.00757","article-title":"Antiviral therapy utilization and 10-year outcomes in resected hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma","volume":"42","author":"Huang","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.surg.2025.109396_bib5","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0037-1601349","article-title":"Liver cancer emergence associated with antiviral treatment: an immune surveillance failure?","volume":"37","author":"Reig","year":"2017","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.surg.2025.109396_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jhep.2016.04.008","article-title":"Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy","volume":"65","author":"Reig","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2025.109396_bib7","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1053\/j.gastro.2019.02.038","article-title":"HCV-induced epigenetic changes associated with liver cancer risk persist after sustained virologic response","volume":"156","author":"Hamdane","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2025.109396_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-Dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.surg.2025.109396_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/j.1477-2574.2011.00330.x","article-title":"A standard definition of major hepatectomy: resection of four or more liver segments","volume":"13","author":"Reddy","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.surg.2025.109396_bib10","series-title":"A language and environment for statistical computing","year":"2016"},{"key":"10.1016\/j.surg.2025.109396_bib11","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/cancers14092295","article-title":"Hepatitis C virus elimination using direct acting antivirals after the radical cure of hepatocellular carcinoma suppresses the recurrence of the cancer","volume":"14","author":"Kuromatsu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.surg.2025.109396_bib12","doi-asserted-by":"crossref","first-page":"125","DOI":"10.17998\/jlc.2022.05.24","article-title":"Effect of direct-acting antivirals for hepatitis C virus-related hepatocellular carcinoma recurrence and death after curative treatment","volume":"22","author":"Ahn","year":"2022","journal-title":"J Liver Cancer"},{"key":"10.1016\/j.surg.2025.109396_bib13","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/hepr.13709","article-title":"Postoperative direct-acting antiviral treatment after liver resection in patients with hepatitis C virus-related hepatocellular carcinoma","volume":"51","author":"Tanaka","year":"2021","journal-title":"Hepatol Res"},{"key":"10.1016\/j.surg.2025.109396_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2147\/JHC.S279657","article-title":"Timing of DAA initiation after curative treatment and its relationship with the recurrence of HCV-related HCC","volume":"7","author":"Gao","year":"2020","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.surg.2025.109396_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/jso.26184","article-title":"Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct-acting antivirals","volume":"122","author":"Tanaka","year":"2020","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.surg.2025.109396_bib16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/hepr.13547","article-title":"Clinical outcomes of direct-acting antiviral treatments for patients with hepatitis C after hepatocellular carcinoma are equivalent to interferon treatment","volume":"50","author":"Tahata","year":"2020","journal-title":"Hepatol Res"},{"key":"10.1016\/j.surg.2025.109396_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/jhbp.1406","article-title":"Comparison of postoperative outcomes in cases achieving sustained virological response with direct-acting antiviral and interferon therapy","volume":"31","author":"Hashimoto","year":"2023","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.surg.2025.109396_bib18","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/gutjnl-2020-323663","article-title":"Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis","volume":"71","author":"Sapena","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.surg.2025.109396_bib19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/jvh.13627","article-title":"Direct-acting antivirals reduce the risk of tumour progression of hepatocellular carcinoma after curative treatment","volume":"29","author":"Ikenaga","year":"2022","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.surg.2025.109396_bib20","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1053\/j.gastro.2019.01.027","article-title":"Direct-acting antiviral therapy not associated with recurrence of hepatocellular carcinoma in a multicenter North American cohort study","volume":"156","author":"Singal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2025.109396_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/medicina58020259","article-title":"The impact of direct-acting antiviral therapy on the risk of recurrence after curative resection in patients with hepatitis-C-Virus-Related early stage hepatocellular carcinoma","volume":"58","author":"Chen","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.surg.2025.109396_bib22","first-page":"5526","article-title":"Comparable benefits of HCV eradication by direct acting antivirals and interferon-based therapy in patients with hepatocellular carcinoma undergoing surgical resection","volume":"11","author":"Wu","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.surg.2025.109396_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cgh.2023.06.026","article-title":"Regional differences in clinical presentation and prognosis of patients with post-sustained virologic response hepatocellular carcinoma","volume":"22","author":"Toyoda","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.surg.2025.109396_bib26","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","article-title":"Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study","volume":"393","author":"Carrat","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2025.109396_bib27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jhep.2017.07.007","article-title":"Hepatocellular carcinoma recurrence after direct antiviral agent treatment: a European multicentre study","volume":"67","author":"Kolly","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2025.109396_bib28","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1002\/cncr.34378","article-title":"Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma","volume":"128","author":"Parikh","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.surg.2025.109396_bib29","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.surg.2025.109396_bib30","doi-asserted-by":"crossref","first-page":"S1230","DOI":"10.1016\/j.annonc.2024.08.2279","article-title":"LBA39 Updated efficacy and safety data from IMbrave050: phase III study of adjuvant atezolizumab (atezo) + bevacizumab (bev) vs active surveillance in patients (pts) with resected or ablated high-risk hepatocellular carcinoma (HCC)","volume":"35","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.surg.2025.109396_bib31","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2024.01.018","article-title":"Navigating the landscape of liver cancer management: study designs in clinical trials and clinical practice","volume":"80","author":"Cabibbo","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.surg.2025.109396_bib32","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0140-6736(24)00800-6","article-title":"Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial","volume":"404","author":"Rose","year":"2024","journal-title":"The Lancet"}],"updated-by":[{"DOI":"10.1016\/j.surg.2026.110228","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000}},{"DOI":"10.1016\/j.surg.2026.110228","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602500248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003960602500248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T04:14:05Z","timestamp":1778040845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003960602500248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":30,"alternative-id":["S003960602500248X"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2025.109396","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2025.109396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109396"}}